Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.144 EUR | -3.94% | -15.24% | -92.80% |
05-29 | Neovacs: mRNA approach validated in preclinical trial | CF |
05-27 | Neovacs: collaboration contract with INSERM team | CF |
- Stock Market
- Equities
- ALNEV Stock
- News NEOVACS
- MarketScreener Editorial Features